Accumulating data suggest that high intrahepatic or circulating PCSK9 levels play an important role in the storage and secretion of lipids (including triglycerides and fatty acids) in vivo13,15,16, contributing to the pathogenesis of NAFLD. Here, PCSK9 is linked to metabolic dysfunction-associated steatotic liver disease.